Psyched Wellness Increases Bought Deal To $5.5 Million

Psyched Wellness (CSE: PSYC) has increased the size of its bought deal private placement as a result of strong demand from shareholders. Previously pegged at $3.0 million, the financing has now nearly doubled to that of $5.5 million.

The financing, lead by Canaccord Genuity, will see units of the company sold at a price of $0.31 per unit. Each unit contains one common share and one common share purchase warrant, with each warrant having an exercise price of $0.43 per common share and an expiry of three years from the date of issue.

Warrants issued under the financing are also subject to an acceleration clause, enabling the company to accelerate the expiry of the warrant if the equity trades above $0.70 for a period of five trading days on a volume weighted basis. An over-allotment option has also been granted to the underwriters.

Net proceeds from the financing are to be used to fully fund pre-clinical trials of the firms amanita muscaria mushroom extract, and to further scientific research on the formulation. Proceeds are also to be spent on general corporate purposes.

Psyched Wellness last traded at $0.37 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Verses Hits Commercialization Stage With Genius AI Platform

Related News

Psyched Wellness Sees Amanita Muscaria Approved As Medicinal Organism By Health Canada

After more than a years worth of development work, Psyched Wellness (CSE: PSYC) this morning...

Wednesday, November 3, 2021, 08:10:25 AM

Psychedelics: Sector Tailwinds To Come – The Daily Dive feat Psyched Wellness CEO Jeff Stevens

Starting off the short Canadian trading week this week on the Daily Dive is that...

Tuesday, May 25, 2021, 01:30:00 PM

Psyched Wellness Files Patent Application For Proprietary AME-1 Extraction Process

Psyched Wellness (CSE: PSYC) has begun the process of protecting its intellectual property. The firm...

Wednesday, March 17, 2021, 07:32:20 AM

Psyched Wellness Attracts Major Investment

Jeffrey Stevens, CEO & Director of Psyched Wellness (CSE: PSYC) joins us in today’s episode...

Friday, June 9, 2023, 01:30:00 PM

Psyched Wellness Launches Study On Mushroom Extract Focused On Gut Health

Psyched Wellness (CSE: PSYC) this morning issued a very brief press release related to ongoing...

Tuesday, March 30, 2021, 08:31:58 AM